Fusion IP

www.biofusion.co.uk Financials
  • Watchlist/Portfolio

    Add to watchlist:

    Only registered members can add into watchlist !

    Register here !
Overview
Financials (in $m unless stated)
Sales 5.894
EBITDA -
Operating Profit 0.984
Pre-tax Profit 1.046
Net Profit 1.046
Capex -
Operating Cash Flow -2.045
Net Working Capital -
Key Ratios
EBITDA Margin -
Operating Profit Margin 16.7%
Net Profit Margin 17.7%
Capex/Sales (%) -
NWC/Sales (%) 0.4x
Asset Turnover 0.2x
Days Inventory - days
Days Receivable -
Days Payable -
Performance (Last 3 Years)
Sales CAGR -
EBITDA CAGR -
Operating Profit CAGR -
Profit CAGR -
Return on Equity
Return on Assets -
Return on Invested Capital (ROIC) -
ROIC - WACC -
Valuation
Market Cap 35.32 m
Price to Earnings -20.38
Price to Book Value -
Price to Tangible Book -
Equity to FCF Yield -
Enterprise Value 36.931
EV to Sales -
EV to EBITDA -
EV to Operating Profit -
EV to Invested Capital -
EV to FCF Yield -
Dividend Yield 0.00
Payout Ratio 0.00
Per Share Data (in GBp unless stated)
Earnings per share (31/07/11) 2.53
Operating Cashflow per share -
Free Cashflow per share -
Dividend per share 0.00
NAV per share -
Cash per share -
Solvency
Intangibles Incl. Excl.
Net debt to Equity % 5.2% -
Cash to Equity % 0.1x -
Gross debt to Equity % 11.6% -
Gross Debt < 1 Year to Equity - -
Net debt to Assets % 10.5x
Net Debt/EBITDA - -
Net Interest Cover - -
Op Cashflow Interest Cover - -
Current Ratio 6.77631578947 -
Quick Ratio 6.77631578947 -
Cash Ratio 5.16315789474 -
Dividend Cover 0.00 -
Key Dates
Latest Dividend Pay date -
Latest Ex-Dividend date -
Last Annual Results 31/01/12
Last Interim Results 31/07/11